PortViewPortView
60 Degrees Pharmaceuticals logo

60 Degrees Pharmaceuticals (SXTP) Stock Analysis

NASDAQHealthcareBiotechnology

$1.04+1.96%
1-year price historyRange $1.02 – $7.20
52-week range$1.04
$1.01$8.62

What 60 Degrees Pharmaceuticals does

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United States. The company currently offers Arakoda, an approved medication for malaria prophylaxis. Its pipeline includes several investigational drugs: Tafenoquine, in its 'Arakoda regimen' formulation, is undergoing Phase IIb clinical trials for potential use against COVID-19. Additionally, Tafenoquine is the subject of Phase IIA clinical studies for conditions such as babesiosis, fungal pneumonias, and candidiasis. Another candidate, Celgosivir, is being developed to address Zika, various respiratory viruses, and dengue fever. Further strengthening its development efforts, 60 Degrees Pharmaceuticals holds a patent license agreement with Tufts Medical Center, collaborating to advance Tafenoquine specifically for the treatment and prevention of babesiosis. The company was established in 2010 and maintains its corporate headquarters in Washington, D.C.

Key metrics

Market cap
$838,812
P/E (TTM)
-0.15
EPS (TTM)
$-6.86
Beta
2.54
Dividend yield
0.00%
Revenue / share
$0.42
50-day avg
$1.37
200-day avg
$2.25
52-week high
$8.62
52-week low
$1.01
CEO
Geoffrey Stuart Dow

ETFs linked to SXTP

Broad-market and Healthcare sector ETFs an investor holding 60 Degrees Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SXTP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SXTP in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals trades under the ticker SXTP on NASDAQ.
Which exchange is SXTP listed on?
SXTP is listed on NASDAQ.
What sector does 60 Degrees Pharmaceuticals operate in?
60 Degrees Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SXTP in a portfolio?
PortView shows SXTP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.